Evidence map›Paper›PMID 39110742›Full record

ArticlePLoS genetics2024

Enhancing portability of trans-ancestral polygenic risk scores through tissue-specific functional genomic data integration.

Bradley Crone, Alan P Boyle

Abstract read
In one paragraph

Article in PLoS genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bradley CroneDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID https://orcid.org/0000-0003-4582-4137
Alan P BoyleDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID https://orcid.org/0000-0002-2081-1105

Funding

Predicting the Impact of Genomic Variation on Cellular StatesU01HG011952 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alan P Boyle · 2021 to 2026
$3.8M
RegulomeDB: A Resource for the Human RegulomeU24HG009293 · NHGRI · STANFORD UNIVERSITY · PI BOYLE, ALAN P, CHERRY, J. MICHAEL · 2020 to 2024
$3.3M
NHGRI NIH HHS U01 HG011952NHGRI NIH HHS U24 HG009293
6 · The paper itself

Abstract

Portability of trans-ancestral polygenic risk scores is often confounded by differences in linkage disequilibrium and genetic architecture between ancestries. Recent literature has shown that prioritizing GWAS SNPs with functional genomic evidence over strong association signals can improve model portability. We leveraged three RegulomeDB-derived functional regulatory annotations-SURF, TURF, and TLand-to construct polygenic risk models across a set of quantitative and binary traits highlighting functional mutations tagged by trait-associated tissue annotations. Tissue-specific prioritization by TURF and TLand provide a significant improvement in model accuracy over standard polygenic risk score (PRS) models across all traits. We developed the Trans-ancestral Iterative Tissue Refinement (TITR) algorithm to construct PRS models that prioritize functional mutations across multiple trait-implicated tissues. TITR-constructed PRS models show increased predictive accuracy over single tissue prioritization. This indicates our TITR approach captures a more comprehensive view of regulatory systems across implicated tissues that contribute to variance in trait expression.

Indexed as

AlgorithmsGenetic Risk ScoreGenome-Wide Association StudyMultifactorial InheritancePolymorphism, Single NucleotideGenomicsHumansLinkage DisequilibriumModels, GeneticOrgan SpecificityPhenotypeQuantitative Trait Loci

Identifiers

PMID39110742
PMCPMC11333000

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.